Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 103
- +20 vs. Q3 2025
- Portfolio value
- $1.78B
- +$477.8M (+36.6%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VERAVera Therapeutics, Inc. | CL A | 3,072,304 | $155.6M | 8.7% | +264,468+9.4% | Added | History |
| GSKGSK plc | ADR | 2,679,721 | $131.4M | 7.4% | +559,275+26.4% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 252,592 | $123.1M | 6.9% | −628−0.2% | Reduced | History |
| ABVXAbivax S.A. | SPONSORED ADS | 657,834 | $88.7M | 5.0% | +231,335+54.2% | Added | History |
| NTRANatera, Inc. | COM | 334,493 | $76.6M | 4.3% | −185,151−35.6% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 3,314,408 | $69.6M | 3.9% | −152,906−4.4% | Reduced | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,782,235 | $55.5M | 3.1% | −142,071−7.4% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 1,197,722 | $55.3M | 3.1% | −224,261−15.8% | Reduced | History |
| TVTXTravere Therapeutics, Inc. | COM | 1,174,968 | $44.9M | 2.5% | −242,236−17.1% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 95,874 | $44.8M | 2.5% | −15,826−14.2% | Reduced | History |
| DHRDanaher Corp | Stock | 186,262 | $42.6M | 2.4% | +86,989+87.6% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 538,218 | $42.6M | 2.4% | −443−0.1% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,434,725 | $39.0M | 2.2% | +280,805+24.3% | Added | History |
| BRKRBruker Corp | COM | 783,789 | $36.9M | 2.1% | +96,660+14.1% | Added | History |
| AVTRAvantor, Inc. | COM | 3,176,644 | $36.4M | 2.0% | +2,252,202+243.6% | Added | History |
| CYHCommunity Health Systems Inc | COM | 7,943,802 | $24.8M | 1.4% | +993,751+14.3% | Added | History |
| EXASExact Sciences Corp | COM | 241,678 | $24.5M | 1.4% | +241,678 | New | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 2,992,895 | $23.3M | 1.3% | +1,619,270+117.9% | Added | History |
| GERNGeron Corp | COM | 17,659,983 | $23.3M | 1.3% | +5,060,981+40.2% | Added | History |
| TECHBIO-TECHNE Corp | COM | 377,405 | $22.2M | 1.2% | −214,135−36.2% | Reduced | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 98,721 | $21.8M | 1.2% | +98,721 | New | History |
| PODDInsulet Corp | Stock | 74,708 | $21.2M | 1.2% | +29,104+63.8% | Added | History |
| BBNXBeta Bionics, Inc. | COM | 678,262 | $20.7M | 1.2% | +678,262 | New | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 660,177 | $20.6M | 1.2% | −703,476−51.6% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 60,862 | $20.1M | 1.1% | −1,958−3.1% | Reduced | History |
| LQDALiquidia Corp | COM NEW | 509,443 | $17.6M | 1.0% | +23,422+4.8% | Added | History |
| ICLRIcon PLC | COM | 95,832 | $17.5M | 1.0% | +40,807+74.2% | Added | History |
| HQYHealthequity, Inc. | COM | 185,739 | $17.0M | 1.0% | +133,351+254.5% | Added | History |
| GKOSGLAUKOS Corp | COM | 147,471 | $16.7M | 0.9% | +147,471 | New | History |
| RVTYRevvity, Inc. | COM | 162,777 | $15.7M | 0.9% | −231,534−58.7% | Reduced | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 420,827 | $14.8M | 0.8% | −67,765−13.9% | Reduced | History |
| ESPREsperion Therapeutics, Inc. | COM | 3,851,133 | $14.2M | 0.8% | +3,851,133 | New | History |
| BIIBBiogen Inc. | COM | 77,944 | $13.7M | 0.8% | +26,179+50.6% | Added | History |
| SEMSelect Medical Holdings Corp | COM | 906,100 | $13.5M | 0.8% | +906,100 | New | History |
| CNCCentene Corp | Stock | 324,092 | $13.3M | 0.7% | +99,542+44.3% | Added | History |
| CGONCG Oncology, Inc. | COM | 308,466 | $12.8M | 0.7% | +308,466 | New | History |
| BMYBristol Myers Squibb Co | Stock | 235,293 | $12.7M | 0.7% | +235,293 | New | History |
| PALIPalisade Bio, Inc. | COM | 5,391,548 | $12.7M | 0.7% | +5,391,548 | New | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 434,634 | $12.6M | 0.7% | +323,168+289.9% | Added | History |
| PHVSPharvaris N.V. | COM | 439,177 | $12.2M | 0.7% | +439,177 | New | History |
| LLYEli Lilly & Co | Stock | 10,623 | $11.4M | 0.6% | +10,623 | New | History |
| EHCEncompass Health Corp | COM | 106,926 | $11.3M | 0.6% | +106,926 | New | History |
| CTMXCytomX Therapeutics, Inc. | COM | 2,507,090 | $10.7M | 0.6% | +2,507,090 | New | History |
| ELVElevance Health, Inc. | Stock | 30,195 | $10.6M | 0.6% | −14,785−32.9% | Reduced | History |
| MNKDMannkind Corp | COM NEW | 1,852,563 | $10.5M | 0.6% | −190,164−9.3% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 231,380 | $10.4M | 0.6% | +231,380 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 48,241 | $10.3M | 0.6% | +48,241 | New | History |
| ISRGIntuitive Surgical Inc | COM NEW | 18,062 | $10.2M | 0.6% | +3,636+25.2% | Added | History |
| ILMNIllumina, Inc. | COM | 76,721 | $10.1M | 0.6% | −46,953−38.0% | Reduced | History |
| ARDXArdelyx, Inc. | COM | 1,715,129 | $10.0M | 0.6% | +285,752+20.0% | Added | History |
| DVAXDynavax Technologies Corp | COM NEW | 605,976 | $9.32M | 0.5% | −87,551−12.6% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 127,561 | $8.87M | 0.5% | −38,830−23.3% | Reduced | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 337,340 | $8.37M | 0.5% | −164,894−32.8% | Reduced | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 358,168 | $8.36M | 0.5% | +7,356+2.1% | Added | History |
| HUMHumana Inc | Stock | 32,462 | $8.31M | 0.5% | +15,810+94.9% | Added | History |
| PNTGPennant Group, Inc. | COM | 293,960 | $8.27M | 0.5% | +255,980+674.0% | Added | History |
| MRNAModerna, Inc. | Stock | 267,823 | $7.90M | 0.4% | +267,823 | New | History |
| MOHMolina Healthcare, Inc. | COM | 45,470 | $7.89M | 0.4% | +36,000+380.1% | Added | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 10,097 | $7.79M | 0.4% | −6,623−39.6% | Reduced | History |
| TYRATyra Biosciences, Inc. | COM | 278,564 | $7.32M | 0.4% | +5,858+2.1% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 317,182 | $7.30M | 0.4% | +317,182 | New | History |
| ANABAnaptysbio, Inc | COM | 120,927 | $5.86M | 0.3% | +120,927 | New | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 93,748 | $5.57M | 0.3% | −52,894−36.1% | Reduced | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 159,676 | $5.43M | 0.3% | +159,676 | New | History |
| IVVDInvivyd, Inc. | COM | 2,140,130 | $5.29M | 0.3% | +92,865+4.5% | Added | History |
| CVSCVS Health Corp | Stock | 63,696 | $5.05M | 0.3% | +63,696 | New | History |
| ACADAcadia Pharmaceuticals Inc | COM | 176,594 | $4.72M | 0.3% | +12,357+7.5% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 52,961 | $4.63M | 0.3% | +52,961 | New | History |
| ZBIOZenas BioPharma, Inc. | COM | 121,016 | $4.39M | 0.2% | −37,726−23.8% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 489,137 | $4.14M | 0.2% | +10,081+2.1% | Added | History |
| ENGNenGene Therapeutics Inc. | COM | 455,835 | $4.12M | 0.2% | +455,835 | New | History |
| BKDBrookdale Senior Living Inc. | COM | 374,929 | $4.05M | 0.2% | +374,929 | New | History |
| NHCNational Healthcare Corp | COM | 28,577 | $3.92M | 0.2% | +28,577 | New | History |
| FTREFortrea Holdings Inc. | COMMON STOCK | 224,139 | $3.87M | 0.2% | +4,755+2.2% | Added | History |
| BVSBioventus Inc. | COM CL A | 471,257 | $3.51M | 0.2% | +37,324+8.6% | Added | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 251,593 | $2.93M | 0.2% | −724,918−74.2% | Reduced | History |
| AVRAnteris Technologies Global Corp. | COM | 500,000 | $2.50M | 0.1% | 00.0% | Unchanged | History |
| AMRNAmarin Corp PLC | SPONSORED ADR | 172,188 | $2.40M | 0.1% | +4,912+2.9% | Added | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 718,582 | $2.34M | 0.1% | +427,909+147.2% | Added | History |
| EOLSEvolus, Inc. | COM | 344,104 | $2.29M | 0.1% | −1,131,005−76.7% | Reduced | History |
| STROSutro Biopharma, Inc. | COM SHS | 193,571 | $2.24M | 0.1% | −35,560−15.5% | ReducedConverted for a 1-for-10 split | History |
| SRZNSurrozen, Inc. | COM NEW | 95,286 | $2.15M | 0.1% | +18,289+23.8% | Added | History |
| EHABEnhabit, Inc. | COM | 218,510 | $2.01M | 0.1% | +218,510 | New | History |
| RAPPRapport Therapeutics, Inc. | COM | 59,233 | $1.80M | 0.1% | −84,332−58.7% | Reduced | History |
| IFRXInflaRx N.V. | COM | 1,757,312 | $1.77M | 0.1% | +26,677+1.5% | Added | History |
| BHVNBiohaven Ltd. | COM | 145,431 | $1.64M | 0.1% | +145,431 | New | History |
| CTNMContineum Therapeutics, Inc. | CL A | 137,493 | $1.57M | 0.1% | +2,874+2.1% | Added | History |
| ALECAlector, Inc. | COM | 1,006,163 | $1.57M | 0.1% | −482,562−32.4% | Reduced | History |
| NVCRNovoCure Ltd | ORD SHS | 120,978 | $1.56M | 0.1% | +120,978 | New | History |
| QUREuniQure N.V. | SHS | 62,820 | $1.50M | 0.1% | −814,553−92.8% | Reduced | History |
| PASGPassage BIO, Inc. | COM | 126,230 | $1.49M | 0.1% | +126,230 | New | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 178,915 | $1.27M | 0.1% | −15,525−8.0% | Reduced | History |
| NVAXNovavax Inc | COM NEW | 181,220 | $1.22M | 0.1% | −61,964−25.5% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 842,023 | $1.03M | 0.1% | +17,429+2.1% | Added | History |
| SVRASavara Inc | COM | 170,195 | $1.03M | 0.1% | +170,195 | New | History |
| EHTHeHealth, Inc. | COM | 222,570 | $1.02M | 0.1% | +94,248+73.4% | Added | History |
| INMDInMode Ltd. | SHS | 61,938 | $909.9K | 0.1% | +61,938 | New | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 260,259 | $629.8K | <0.1% | +260,259 | New | History |
| EDITEditas Medicine, Inc. | COM | 290,919 | $596.4K | <0.1% | +290,919 | New | History |
| SLQTSelectQuote, Inc. | COM | 357,661 | $504.3K | <0.1% | +357,661 | New | History |
Options (4)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $138.2M | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $30.6M | – |
| iShares Tr464287432 | 20 YR TR BD ETF | $20.0M | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $12.1M | – |
Sold out since Q3 2025 (14)
Positions held at the end of Q3 2025 that are gone from this filing.
| Security | Class | Shares in Q3 2025 | Value in Q3 2025 | % of portfolio in Q3 2025 | History |
|---|---|---|---|---|---|
| ZIMVZimVie Inc. | Stock | 2,079,380 | $39.4M | 3.0% | History |
| RGENRepligen Corp | COM | 105,087 | $14.0M | 1.1% | History |
| Avidity Biosciences, Inc.05370A108 | COM | 302,911 | $13.2M | 1.0% | – |
| NVONovo Nordisk A S | ADR | 217,708 | $12.1M | 0.9% | History |
| ETNB89bio, Inc. | COM | 392,441 | $5.77M | 0.4% | History |
| MRUSMerus N.V. | COM | 48,054 | $4.52M | 0.3% | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 49,314 | $3.62M | 0.3% | History |
| NKTRNektar Therapeutics | COM NEW | 49,890 | $2.84M | 0.2% | History |
| GOSSGossamer Bio, Inc. | COM | 925,233 | $2.43M | 0.2% | History |
| KURAKura Oncology, Inc. | COM | 263,628 | $2.33M | 0.2% | History |
| KRROKorro Bio, Inc. | COM | 20,856 | $998.8K | 0.1% | History |
| PVLAPalvella Therapeutics, Inc. | COM | 11,343 | $711.1K | 0.1% | History |
| REPLReplimune Group, Inc. | COM | 59,992 | $251.4K | <0.1% | History |
| DYNDyne Therapeutics, Inc. | COM | 10,000 | $126.5K | <0.1% | History |